Tau Pathology and Parietal White Matter Lesions Have Independent but Synergistic Effects on Early Development of Alzheimer's Disease

by Joakim Hertze, Sebastian Palmqvist, Lennart Minthon, Oskar Hansson
Published 2013-04-01

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

by Claudia Cicognola, Shorena Janelidze, Joakim Hertze, Henrik Zetterberg, Kaj Blennow, Niklas Mattsson-Carlgren, Oskar Hansson
Published 2021-03-01

Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.

by Sebastian Palmqvist, Joakim Hertze, Lennart Minthon, Carina Wattmo, Henrik Zetterberg, Kaj Blennow, Elisabet Londos, Oskar Hansson
Published 2012-01-01

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.

by Mikko Hölttä, Oskar Hansson, Ulf Andreasson, Joakim Hertze, Lennart Minthon, Katarina Nägga, Niels Andreasen, Henrik Zetterberg, Kaj Blennow
Published 2013-01-01